INTRODUCTION: Little is known about the completeness and timely administration of recommended standard immunizations in Germany. The goal of this study was to determine compliance with official standard immunization recommendations in adolescents attending secondary schools in the city of Erlangen, Germany. METHODS: Adolescents who were attending 5th grade (at approximately 11 years of age), 8th grade (14 years), or 10th and 11th grade (16-17 years) classes at any of the 13 of 14 schools that had agreed to participate were eligible to be enrolled. RESULTS: While coverage for the primary series of diphtheria, tetanus and poliomyelitis immunizations was satisfactory (98%), coverage for measles-mumps-rubella immunizations (dose 1: 89-96%; dose 2: 60-76%) and hepatitis B (doses 1-3: 61%) was suboptimal. Of note, 39% of students had not received any immunization against pertussis. Completion of immunization series generally was significantly delayed. Furthermore, rates for recommended booster doses in adolescence were disappointingly low with 21% for tetanus component vaccines and <10% for the fifth dose of pertussis. CONCLUSIONS: Significant immunization gaps for all recommended standard immunizations in adolescents were detected. This puts individuals at risk for serious vaccine-preventable diseases, contributes to suboptimal herd immunity in the population under study leaving the potential for future epidemics, and impedes national and international targets of disease reduction or elimination.
INTRODUCTION: Little is known about the completeness and timely administration of recommended standard immunizations in Germany. The goal of this study was to determine compliance with official standard immunization recommendations in adolescents attending secondary schools in the city of Erlangen, Germany. METHODS: Adolescents who were attending 5th grade (at approximately 11 years of age), 8th grade (14 years), or 10th and 11th grade (16-17 years) classes at any of the 13 of 14 schools that had agreed to participate were eligible to be enrolled. RESULTS: While coverage for the primary series of diphtheria, tetanus and poliomyelitis immunizations was satisfactory (98%), coverage for measles-mumps-rubella immunizations (dose 1: 89-96%; dose 2: 60-76%) and hepatitis B (doses 1-3: 61%) was suboptimal. Of note, 39% of students had not received any immunization against pertussis. Completion of immunization series generally was significantly delayed. Furthermore, rates for recommended booster doses in adolescence were disappointingly low with 21% for tetanus component vaccines and <10% for the fifth dose of pertussis. CONCLUSIONS: Significant immunization gaps for all recommended standard immunizations in adolescents were detected. This puts individuals at risk for serious vaccine-preventable diseases, contributes to suboptimal herd immunity in the population under study leaving the potential for future epidemics, and impedes national and international targets of disease reduction or elimination.
Authors: P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams Journal: Am J Prev Med Date: 2000-01 Impact factor: 5.043
Authors: Kieran J Fogarty; Mehran S Massoudi; William Gallo; Francisco M Averhoff; Hussain Yusuf; Daniel Fishbein Journal: Public Health Rep Date: 2004 Mar-Apr Impact factor: 2.792
Authors: Elizabeth T Luman; Lawrence E Barker; Kate M Shaw; Mary Mason McCauley; James W Buehler; Larry K Pickering Journal: JAMA Date: 2005-03-09 Impact factor: 56.272
Authors: P G Szilagyi; L E Rodewald; S G Humiston; R F Raubertas; L A Cove; C B Doane; P H Lind; M S Tobin; K J Roghmann; C B Hall Journal: Pediatrics Date: 1993-01 Impact factor: 7.124
Authors: Irine-Ikbale Sakou; Artemis K Tsitsika; Vassiliki Papaevangelou; Eleni C Tzavela; Donald E Greydanus; Maria N Tsolia Journal: Eur J Pediatr Date: 2011-04-05 Impact factor: 3.183
Authors: Ingrid T Katz; Norma C Ware; Glenda Gray; Jessica E Haberer; Claude A Mellins; David R Bangsberg Journal: Sex Health Date: 2010-09 Impact factor: 2.706
Authors: E van Boetzelaer; A Daae; B A Winje; D F Vestrheim; A Steens; P Stefanoff Journal: Hum Vaccin Immunother Date: 2021-10-06 Impact factor: 3.452